Omega 3 fatty acids are a type of fat that are considered essential for overall health of humans. A lot of health experts recommend the same and a lot of research has went into discovering the many health benefits of omega-3 fatty acids.
The global hyperbaric oxygen therapy (HBOT) devices market is anticipated to reach US$ 368.36 Mn by 2029. Increasing preference of physicians to use oxygen therapy has been greatly contributing to the market growth of HBOT devices. HBOT devices have received FDA approval for treatment of necrotizing soft tissue infection, injuries, burns, decompression sickness and others. Off-label use of HBOT devices encompasses treatment of brain injuries and even cancer, despite lack of robust clinical evidence.
According to the Cleveland Clinic, Aspergillosis is an infection or allergic reaction caused by various kinds of molds found on plants, soil, building materials or rotting vegetables. Aspergillosis treatment market can be segmented on the basis of several types such as allergic bronchopulmonary aspergillosis (ABPA), allergic Aspergillus sinusitis, aspergilloma, chronic pulmonary aspergillosis, invasive aspergillosis and cutaneous (skin) aspergillosis. ABPA is observed as one of the most common aspergillosis in which inflammation in the lungs and allergy symptoms such as coughing and wheezing are observed.
Krill are small, up to 6 cm, shrimplike shellfish at the base of the ocean’s food chain. Including 85 species of krill, the total estimated biomass of between 400 Mn and 600 Mn tones in 2016-17. For claimed health benefits of krill oil, including the management and treatment of conditions, such as hyperlipidemia, inflammation, and arthritis, there has been a noticeable increase in research and promotion of krill oil in recent years.
Amyloidosis is a rare disease causes due to building up of amyloid an abnormal protein which usually gets produced in bone marrow and deposits in any tissue or organ. According to The Amyloidosis Foundtion, in the U.S. amyloidosis is the most common type, with approximately 4,500 new cases diagnosed every year. It usually affects people from age group 50-80; however, there are a few cases of people being diagnosed as early as their late 20s and overall incidence statistics suggest that two-thirds of the patients are male.
Nonalcoholic steatohepatitis (NASH) reatment market is Expected to Grow at 38% by 2033. Nonalcoholic steatohepatitis (NASH) is also known as ‘fatty liver’ a disorder that develops in patients who are not alcoholic; mainly causes liver damage that is diagnostically indistinguishable from alcoholic hepatitis. The key risk factors observed in patients suffering from NASH are obesity, glucose intolerance, and dyslipidemia. The challenges that are faced in the diagnosis of the disease are mainly due to poor understanding of pathogenesis linked to insulin resistance especially in obesity or metabolic syndrome.
According to American Liver Foundation, primary biliary cholangitis formerly known as primary biliary cirrhosis (PBC), is a chronic liver disease that gradually destroys the medium-sized bile ducts within the liver. These bile ducts are damaged by inflammation which causes bile to remain in the liver, where gradual injury damages liver cells and causes liver cirrhosis. As cirrhosis progresses and the amount of scar tissue in the liver increases, the liver loses its ability to function
Grape seed extracts is an industrial derivative of grape seeds; it contains a vast array of health-benefiting ingredients, such as carbohydrates, protein, polyphenols and lipids. Grape seed extracts also protect the blood vessel walls from inflammatory stress, the brain from low oxygen states and the skin from UV radiation damage. Due to its benefits on these systems, it has been shown to reduce the risk of skin cancer, protect against dementia and improve blood pressure.
The thyroid gland disorders treatment market is propelling due to the factors such as rise in the patient base suffering from thyroid disorders, rising geriatric population and consistent introduction of innovative and novel therapeutics by market players leading to the growth of the market. Asia Pacific is expected to be the fastest growing market in the thyroid gland disorder treatment market due large patient base leading to large consumption of generic drugs for the treatment of thyroid diseases, especially in the countries such as China, India and Japan.
Geriatric population is growing with the rising global population, and rising patient base suffering from ocular and eye related disorders has been a major growth driver that have urged the advent of ophthalmic drugs market. In the next few years the demand for ophthalmic drugs is expected to increase significantly in the emerging economies such as China and India.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
